Department of Oral Medicine & Radiology KAHER's KLE Vishwanath Katti Institute of Dental Sciences, Constituent Unit of KLE Academy of Higher Education & Research, Nehru Nagar, Belagavi, Karnataka, 590010, India.
Support Care Cancer. 2023 Jul 17;31(8):470. doi: 10.1007/s00520-023-07920-2.
Management of head and neck cancers requires a multidisciplinary approach where surgery followed by radio and chemotherapy is the mainstay of treatment. The above-mentioned treatment can cause mucositis, a severely debilitating side effect. This can have a significant impact on quality of life. A recent advancing mode of drug delivery is the bioadhesive system. This interacts with mucosa by adhering to it and thereby improving the efficacy of the therapeutic agent delivered.
The purpose of this systematic review is to evaluate the effectiveness of bioadhesives in reducing oral mucositis and relieving pain associated with mucositis in head and neck cancer patients receiving radio-chemotherapy.
Studies assessing the effectiveness of bioadhesives for the treatment of radiation-induced oral mucositis were retrieved from specialized databases (PubMed/MEDLINE, Scopus, ProQuest, Google Scholar, LILACS, OpenGrey) as well as institutional repositories. Data on incidence, pain reduction, resolution, and improvement of oral mucositis using bioadhesive were compiled. A Cochrane tool was used for randomized controlled trials and a JBI tool for non-randomized controlled trials and observational studies to assess the quality of included studies. Based on the eligible study data, a meta-analysis was conducted with STATA version 16, 2019 software, and 95% confidence intervals and p values greater than 0.05.
A total of 15 studies were included which assessed the effectiveness of bioadhesives in managing mucositis and its associated pain. Studies included in the review described either reduction, resolution, or incidence of oral mucositis respectively. A total of three meta-analyses were conducted to assess the incidence of oral mucositis and the pain associated with it, as well as the reduction in incidence. Bioadhesives showed statistically significant differences in the incidence of severe mucositis (p = 0.04). A meta-analysis comparing bioadhesives efficacy in reducing mucositis and pain associated with it found no statistically significant differences (p = 0.36).
Bioadhesives are emerging as a novel drug delivery method for treating radio-chemotherapy-induced oral mucositis because of their rapid absorption and easy application. Regardless of its benefits, clinical trials comparing it with conventional treatment methods are necessary to assess its efficacy in treating oral mucositis.
头颈部癌症的治疗需要多学科方法,手术结合放化疗是主要的治疗方法。上述治疗会导致黏膜炎,这是一种严重的致残副作用。这会对生活质量产生重大影响。最近药物输送的一种先进模式是生物黏附系统。它通过黏附在黏膜上来与黏膜相互作用,从而提高所输送的治疗剂的疗效。
本系统评价的目的是评估生物黏附剂在减轻头颈部癌症患者接受放化疗后口腔黏膜炎和缓解黏膜炎相关疼痛方面的有效性。
从专门的数据库(PubMed/MEDLINE、Scopus、ProQuest、Google Scholar、LILACS、OpenGrey)以及机构知识库中检索评估生物黏附剂治疗放射性口腔黏膜炎效果的研究。编译了使用生物黏附剂减少口腔黏膜炎发生率、减轻疼痛、缓解和改善口腔黏膜炎的数据。使用 Cochrane 工具评估随机对照试验,使用 JBI 工具评估非随机对照试验和观察性研究,以评估纳入研究的质量。根据合格研究数据,使用 STATA 版本 16、2019 软件进行荟萃分析,置信区间为 95%,p 值大于 0.05。
共有 15 项研究纳入了评估生物黏附剂在管理黏膜炎及其相关疼痛方面的有效性。综述中纳入的研究分别描述了口腔黏膜炎的减少、缓解或发生率。共进行了三项荟萃分析,以评估口腔黏膜炎的发生率及其相关疼痛,以及发生率的降低。生物黏附剂在严重黏膜炎的发生率方面具有统计学显著差异(p = 0.04)。比较生物黏附剂在减轻黏膜炎及其相关疼痛方面的疗效的荟萃分析发现,差异无统计学意义(p = 0.36)。
生物黏附剂作为一种治疗放化疗引起的口腔黏膜炎的新型药物输送方法,因其吸收迅速、使用方便而备受关注。尽管有其益处,但仍需要进行临床试验来比较其与常规治疗方法,以评估其治疗口腔黏膜炎的疗效。